Gatchalian, program manager, Addiction Recovery Research Center, Fralin Biomedical Research Institute at VTC Amber Kelly, graduate student, Translational Biology, Medicine, and Health Graduate Program Alexandra DiFeliceantonio, assistant professor, Fralin Biomedical Research Institute at VTC, associate director, Center for Health Behaviors Research
This information relates to clinical research and does not indicate approved dosing or recommended use
Semaglutide: Weight Loss: Studies, including one published in the New England Journal of Medicine (NEJM), show an average weight loss of 15% of initial body weight with Semaglutide
Reduced appetite and mild fatigue [1]
Youre talking to someone who gets why youre pursuing this in the first place
Atualmente existem medicamentos aprovados para obesidade e diabetes tipo 2 que atuam em receptores relacionados, como agonistas de GLP-1 e agonistas duais de GLP-1/GIP, que j possuem registro em diversas agncias regulatrias